Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Sandri

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancers|April 3, 2021
Which Is the Best Treatment in Recurrent Thymoma? A Systematic Review and Meta-AnalysisMarco Chiappetta, Ugo Grossi, Isabella Sperduti, et al.
Clinical Lung Cancer|November 18, 2018
Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?Monica Casiraghi, Juliana Guarize, Alberto Sandri, et al.
Cancers|June 2, 2021
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural MesotheliomaDario P Anobile, Paolo Bironzo, Francesca Picca, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 24, 2022
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesotheliomaIris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, et al.
Translational Lung Cancer Research|January 10, 2022
Expert consensus on resection of chest wall tumors and chest wall reconstructionLei Wang, Xiaolong Yan, Jinbo Zhao, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancers|April 3, 2021
Which Is the Best Treatment in Recurrent Thymoma? A Systematic Review and Meta-AnalysisMarco Chiappetta, Ugo Grossi, Isabella Sperduti, et al.
Clinical Lung Cancer|November 18, 2018
Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?Monica Casiraghi, Juliana Guarize, Alberto Sandri, et al.
Cancers|June 2, 2021
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural MesotheliomaDario P Anobile, Paolo Bironzo, Francesca Picca, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 24, 2022
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesotheliomaIris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, et al.
Translational Lung Cancer Research|January 10, 2022
Expert consensus on resection of chest wall tumors and chest wall reconstructionLei Wang, Xiaolong Yan, Jinbo Zhao, et al.
Pageof 4